TY - JOUR
T1 - Trajectory of cost overtime after psychotherapy for depression in older Veterans via telemedicine
AU - Egede, Leonard E.
AU - Gebregziabher, Mulugeta
AU - Walker, Rebekah J.
AU - Payne, Elizabeth H.
AU - Acierno, Ron
AU - Frueh, B. Christopher
N1 - Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Background Little evidence exists regarding the costs of telemedicine, especially considering changes over time. This analysis aimed to analyze trajectory of healthcare cost before, during, and after a behavioral activation intervention delivered via telepsychology and same-room delivery to elderly Veterans with depression. Methods 241 participants were randomly assigned into one of two study groups: behavioral activation for depression via telemedicine or via same-room treatment. Patients received 8 weeks of weekly 60-min individual sessions of behavioral activation for depression. Primary outcomes were collected at 12-months. Inpatient, outpatient, pharmacy, and total costs were collected from VA Health Economics Resource Center (HERC) datasets for FY 1998–2014 and compared between the two treatment groups. Generalized mixed models were used to investigate the trajectories over time. Results Overall cost, as well as, outpatient and pharmacy cost show increasing trend over time. Unadjusted and adjusted trajectories over time for any cost were not different between the two treatment groups. There was a significant overall increasing trend over time for outpatient (p<0.001) and total cost (p<0.001) but not for inpatient (p=0.543) or pharmacy cost (p=0.084). Limitations Generalizability to younger, healthier populations may be limited due to inclusion criteria for study participants. Conclusion Healthcare costs before, during, and after intervention did not differ between the telemedicine and in-person delivery methods. Outpatient costs accounted for most of the increasing trend of cost over time. These results support policies to use both telehealth and in-person treatment modalities to effectively and efficiently provide high quality care.
AB - Background Little evidence exists regarding the costs of telemedicine, especially considering changes over time. This analysis aimed to analyze trajectory of healthcare cost before, during, and after a behavioral activation intervention delivered via telepsychology and same-room delivery to elderly Veterans with depression. Methods 241 participants were randomly assigned into one of two study groups: behavioral activation for depression via telemedicine or via same-room treatment. Patients received 8 weeks of weekly 60-min individual sessions of behavioral activation for depression. Primary outcomes were collected at 12-months. Inpatient, outpatient, pharmacy, and total costs were collected from VA Health Economics Resource Center (HERC) datasets for FY 1998–2014 and compared between the two treatment groups. Generalized mixed models were used to investigate the trajectories over time. Results Overall cost, as well as, outpatient and pharmacy cost show increasing trend over time. Unadjusted and adjusted trajectories over time for any cost were not different between the two treatment groups. There was a significant overall increasing trend over time for outpatient (p<0.001) and total cost (p<0.001) but not for inpatient (p=0.543) or pharmacy cost (p=0.084). Limitations Generalizability to younger, healthier populations may be limited due to inclusion criteria for study participants. Conclusion Healthcare costs before, during, and after intervention did not differ between the telemedicine and in-person delivery methods. Outpatient costs accounted for most of the increasing trend of cost over time. These results support policies to use both telehealth and in-person treatment modalities to effectively and efficiently provide high quality care.
KW - Behavioral activation
KW - Cost
KW - Depression
KW - Elderly
KW - Telemedicine
KW - Telepsychology
UR - http://www.scopus.com/inward/record.url?scp=85007545283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007545283&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2016.09.044
DO - 10.1016/j.jad.2016.09.044
M3 - Article
C2 - 27721190
AN - SCOPUS:85007545283
VL - 207
SP - 157
EP - 162
JO - J Affect Disord
JF - J Affect Disord
SN - 0165-0327
ER -